Dexcel Pharma Technologies Company Profile

18:32 EDT 1st August 2014 | BioPortfolio

Dexcel is a research-based international specialty pharmaceutical company dedicated to treating and preventing human disease through discovery, development, manufacturing and commercialization of innovative pharmaceutical products based on sophisticated proprietary controlled release oral solid dosage form drug delivery technologies. Dexcel was founded in Israel in 1965 and is a private healthcare company, fully owned and operated by its President and CEO, Mr. Dan Oren (See "Executive Team")

Location

Wainwright Building 229 West Bute Street Suite 407
Norfolk
Virginia
23510
United States of America

Contact

Phone: 1-757- 627- 0066


News Articles [1278 Associated News Articles listed on BioPortfolio]

CSPC Pharma Out-Licenses Western Rights for Cancer Drug to Dexcel

CSPC Pharmaceutical Group, headquartered in China's Heibei Province,  has partnered with Dexcel Pharma Technologies to co-develop and commercialize a generic oncology drug in the US, Europe and e...

Week in Review: Aslan In-Licenses Novel Asthma mAb from CSL

Aslan Pharma of Singapore acquired global rights to develop a novel monoclonal antibody to treat asthma from Australia’s CSL Limited; NeoStem out-licensed China rights for its liver cancer immun...

ANI Pharmaceuticals Signs Exclusive License and Supply Agreement with Dexcel Pharma Technologies Ltd.

BAUDETTE, Minn., June 18, 2014 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has signed an exclusive license and supply agreement with Dexcel Pharma Technologies Ltd. ("Dexcel") for an...

Pharma Summit: Rethinking the future – new business models for pharma

The way pharma works needs to change with an increasing focus on collaborations, sharing data and access to medicines, according to a panel discussion at The Economist’s Pharma Summit in London yest...

Pharma Stocks under Review -- Impax Laboratories, Sanofi, GW Pharma, AcelRx Pharma, and Salix Pharma

LONDON, July 23, 2014 /PRNewswire/ -- On Tuesday, July 22, 2014, the NASDAQ Composite ended at 4,456.02, up 0.71%, the Dow Jones Industrial Average finished the day 0.36% higher at 17,113.54, and ...

Download: The future of Pharma

At DigiPharm 2013, we were joined by Professor Brian D. Smith, author of “The Future of Pharma” who gave an in-depth presentation on how pharma has evolved and where it is heading. What sc...

Pharma Stocks on our Radar -- Research on AVANIR Pharma, Zoetis, Salix Pharma, and Jazz Pharma

LONDON, April 10, 2014 /PRNewswire/ -- The trading session on Wednesday, April 09, 2014 ended on a positive note as the Dow Jones Industrial Average finished at 16,437.18, up 1.11% and the NASDAQ ...

Technical Pulse on Pharma Stocks -- Research on Valeant Pharma Intl., Acura Pharma, Teva Pharma Industries, and Lannett

LONDON, June 11, 2014 /PRNewswire/ -- On Tuesday, June 10, 2014, the NASDAQ Composite ended at 4,338.00, up 0.04%, the Dow Jones Industrial Average finished the day 0.02% higher at 16,945.92, and ...

Drugs and Medications [266 Associated Drugs and Medications listed on BioPortfolio]

Omeprazole [Dexcel Pharma Technologies Ltd.]

Omeprazole Delayed Release Tablets, 20 mg

Omeprazole [Dexcel Pharma Technologies Ltd.]

Omeprazole Delayed Release Tablets, 20 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Clinical Trials [36 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily

This is 2-armed parallel group, prospective, randomized, open-label, multicenter Phase 3 controlled trial to establish the efficacy and safety of conversion from maintenance immunosuppress...

Development of a New Method for Analgesia

Aim: To examine a new method to perform local anesthesia in order to diminish the inconvenience by the procedure in patients before performing intubation or oesophagogastroduodenoscopy.

Companies [635 Associated Companies listed on BioPortfolio]

Dexcel Pharma Technologies, Ltd.

Founded in 1968 and headquartered in Or Akiva, Israel, Dexcel Pharma is a privately-held, international specialty pharmaceutical company. It has a presence in 20 countrie...

Dexcel Pharma Technologies

Dexcel is a research-based international specialty pharmaceutical company dedicated to treating and preventing human disease through discovery, development, manufacturing and commercialization of inno...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies,...

More Information about "Dexcel Pharma Technologies" on BioPortfolio

We have published hundreds of Dexcel Pharma Technologies news stories on BioPortfolio along with dozens of Dexcel Pharma Technologies Clinical Trials and PubMed Articles about Dexcel Pharma Technologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dexcel Pharma Technologies Companies in our database. You can also find out about relevant Dexcel Pharma Technologies Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Relevant Topic

Pharmacy
Latest News Clinical Trials Research Drugs Reports Corporate
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record